Actually Dr. Glass will be doing the presentation next week in San Diego at the ANA conference. Also CNN may alos be doing a story on the patient who has shown considerable improvement.
Far from a cure but at least they are on the right track and showing promise. Remember this the only stem...
Update...actually Dr. Glass will be doing the update next week. CNN may also end up doing a story on a patient that has shown substantial improvement. Far from a cure but at least they are headed in the right direction.
Wall Street Webcasting - Neuralstem, Inc.
If you go to the link and register (it's free) just make up a company name, I just put in ALS, you can listen to the podcast and advance through the slides. The first half of the podcast mostly discusses the trial taking place at emory. At about the...
No from what I understand he was in the last group and was done in 2011. It is not a matter of deteriration it is the fact that he showed considerable improvements.
You are right there seems to always be a carrot out there that never comes to fruition. I pray that this is not that scenario...
I meant to say that the secondary outcomes are the efficacy data. The primary outcomes is the saftey data. Both are being measured both prior to the surgery and post surgery.
Here is the link to the trial on the CDC website as you can see while it is a safety study and that is the primary outcome they are recording and reporting to the FDA the efficacy data.
Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis...
trfogey ypu are correct. My apologies. I guess I have been so excited about what I have seen and heard and got carried away. Your other point is extremely astute as well. My understanding is they did go back and re diagnose the patient from the beginning to confirm the original diagnosis...